avVaa World Health Care Products, Inc. Announces Significant Progress with Key Vendors...

* Reuters is not responsible for the content in this press release.

Mon Jun 1, 2009 8:01am EDT

avVaa World Health Care Products, Inc. Announces Significant Progress with Key
Vendors for the Launch of the Neuroskin(R) DRTV Campaign

LUMBY, BC, June 1 /PRNewswire/ - avVaa World Health Care Products Inc. (Pink
Sheets: AVVH), a global biotechnology company, manufacturer and distributor of
nationally branded therapeutic, natural skin and health care products,
announces that work with key vendors for the Neuroskin(R) direct response
television ("DRTV") campaign is underway and progressing smoothly. The
importance of working with experienced vendors for all aspects of the
Neuroskin(R) DRTV campaign is critical to a successful product launch.
Lorie Campbell-Farley, President/COO/Co Founder, stated today, "that we are
working with key vendors of which all are experts at running DRTV campaigns.
The Vendors are working together to put together a successful product launch
for the Neuroskin Psoriasis Relief product. These Vendors include:

    -   An infomercial production company
    -   An infomercial media buyer
    -   An infomercial media funder
    -   Telemarketing firm experienced at working with direct response TV
        campaigns
    -   A credit card processor
    -   A fulfillment house


Ms. Farley states, "it is in the best interest of all the vendors for the
Neuroskin(R) Psoriasis Relief by avVaa to be a success. The vendor's
compensation is typically tied into the DRTV campaign being profitable and
selling a high volume of the Neuroskin(R) Psoriasis Relief."

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that
specializes in effective, all natural, therapeutic skin care products that
improve quality of life and well being for consumers. avVaa's patented
European skin care formulas are scientifically registered, FDA-Compliant, and
were developed to relieve and treat the symptoms of common skin ailments,
including eczema, psoriasis and acne. avVaa is poised to manufacture and
market its OTC Neuroskin(r) line of skin care products through mass, food and
drug channels in the United States and globally. The Company's secondary line
of equine and pet care related products are already being distributed
throughout all of Canada. For more information, visit:
www.avvaa.comhttp://www.avvaa.com

Safe Harbor: Statements contained in this press release that are not based
upon current or historical fact are forward looking in nature.
Such forward-looking statements are subject to risks and uncertainties, which
could cause actual results to differ materially from estimated results.
Management cautions that all statements as to future results of operations are
necessarily subject to risks, uncertainties, and events that may be beyond the
control of avVaa World Health Care Products, Inc. and no assurance can be
given that such results will be achieved.
Potential risks and uncertainties include but are not limited to the ability
to procure, properly price, retain, and successfully complete projects, the
availability of technical personnel, changes in technology, and competition.

SOURCE  avVaa World Helath Care Products

avVaa World Health Care Products: Jack Farley, Chairman, CEO,
jfarley@avvaa.com; Lorie Campbell-Farley, President, COO, lcfarley@avvaa.com,;
Investor Relations: Merle Goertz (West Coast), (604) 688-2349
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.